Oncternal Therapeutics

ONCT · NASDAQ

$0.5266−$0.1673 (−24.11%)TodayMarket closed · Dec 2, 4:00 PM ET

No price history for this range.

About ONCT

Oncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. The company is headquartered in San Diego, California and currently employs 27 full-time employees. The firm is focused on the development of oncology therapies for the treatment of patients with cancers that have critical unmet medical needs. The Company’s product candidates include ONCT-534, ONCT-808, Zilovertamab, and ONCT-216. ONCT-534 is a dual-action androgen receptor inhibitor (DAARI), for the treatment of advanced castration-resistant prostate cancer (CRPC) and other androgen receptor (AR) driven diseases. ONCT-808 is an autologous chimeric antigen receptor (CAR-T) therapy that targets ROR1 for the treatment of hematologic malignancies and solid tumors. Zilovertamab is an investigational, humanized, monoclonal antibody designed to inhibit the function of Receptor tyrosine kinase-like Orphan Receptor 1 (ROR1). Zilovertamab has been evaluated in an investigator-initiated Phase 1b study of zilovertamab in combination with docetaxel in patients with mCRPC.

Employees: 29
Headquarters: San Diego, California
Listed: Feb 3, 2004
Sector: Health Care
Industry: Biotechnology
Website: oncternal.com

Leadership

Oncternal Therapeutics executives
Name	Title	Since	Age
David Hale	—	—	75
James Breitmeyer	—	2019	70
Richard Vincent	—	—	61
Rajesh Krishnan	—	—	51
Chase Leavitt	—	—	42
Michael Carter	—	—	86
Jill Desimone	—	—	68
Daniel Kisner	—	—	77
William Larue	—	—	72
Rosemary Mazanet	—	—	68
Charles Theuer	—	—	60
Robert Wills	—	2015	70

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Oncternal Therapeutics suppliers and customers
Company	Relationship	Country	Correlation
Shanghai Pharm Hldg H	Supplier and customer	CN	0.67
Celularity A CELU	Supplier and customer	US	0.10
AbbVie ABBV	Supplier and customer	US	-0.90
University of Texas M.D. Anderson Cancer Center	Supplier and customer	US	—
State of California	Customer	US	—
United States	Customer	US	—
Georgetown University	Supplier and customer	US	—
University of California	Supplier and customer	US	—
University of Tennessee	Supplier and customer	US	—
Miltenyi Biotec GmbH	Supplier and customer	DE	—

Similar companies

Companies in the same industry as Oncternal Therapeutics

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.